Company Filing History:
Years Active: 2019-2020
Title: Innovations of Manu Thomas Kalathottukaren
Introduction
Manu Thomas Kalathottukaren is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of biomedical research, particularly in the development of antithrombotic compounds. With a total of 2 patents, his work focuses on innovative methods for treating various thrombotic conditions.
Latest Patents
Kalathottukaren's latest patents include groundbreaking work on antithrombotic compounds and their methods and uses. These patents detail polymers and methods designed to bind phosphate-containing biological macromolecules. Specifically, the innovations aim to inhibit thrombin binding to polyphosphate, serving as an antithrombotic agent for the treatment of conditions such as stroke, acute coronary syndrome, pulmonary embolism, atrial fibrillation, and various forms of thromboembolism. The applications of his work extend to addressing disseminated intravascular coagulation (DIC), deep vein thrombosis (DVT), peripheral artery disease, trauma-induced coagulopathy, and cancer-associated thrombosis, among others.
Career Highlights
Throughout his career, Kalathottukaren has been associated with prestigious institutions such as the University of British Columbia and the University of Illinois. His research has significantly advanced the understanding and treatment of thrombotic disorders, showcasing his commitment to improving patient outcomes through innovative solutions.
Collaborations
Kalathottukaren has collaborated with esteemed colleagues, including Jayachandran N Kizhakkedathu and James H Morrissey. These partnerships have further enriched his research and contributed to the development of effective therapeutic strategies.
Conclusion
Manu Thomas Kalathottukaren stands out as a prominent inventor in the field of biomedical research, with a focus on antithrombotic innovations. His contributions are paving the way for new treatments that can significantly impact patient care and outcomes.